Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
See Latest ArticlesSerum levels of HER2/neu, a potential alternative to tissue specimen levels in the management of metastatic breast cancer: a case report and literature review
Community Oncology , 10/09/09
Swayampakula AK et al. – The role of the serum HER2/neu assay in the management of metastatic breast cancer is still evolving. The authors report the case of a 78–year–old woman who was treated with modified radical mastectomy and tamoxifen for stage II infiltrating ductal carcinoma in 1991. This case demonstrates the potential utility of assessing HER2/neu levels in serum as an alternative to tissue specimens in patients who have no tissue available for testing.
Jame Abraham, 10/11/09
| In patients with limited access to tissue, this serum testing could be considered. That will provide life saving information for the patients. |
Related Articles
Novel therapeutic approaches to the treatment of metastatic breast cancer
Cancer Treatment Reviews, 11/05/09
Relevance Score: 83%
Pathological and molecular characteristics distinguishing contralateral metastatic from new primary breast cancer
Annals of Oncology, 11/04/09
Relevance Score: 83%
The GAB2 signaling scaffold promotes anchorage independence and drives a transcriptional response associated with metastatic progression of breast cancer
Oncogene, 10/26/09
Relevance Score: 83%
Hormone receptor expression is associated with a unique pattern of metastatic spread and increased survival among HER2-overexpressing breast cancer patients
American Journal of Clinical Oncology, 10/06/09
Relevance Score: 83%
Quality of life and depression among metastatic breast cancer patients
Medical Oncology, 10/05/09
Relevance Score: 83%
Today in Breast...keeping you current
Receive free subspecialty "5-minute updates" via email
c-Jun activation is required for 4-hydroxytamoxifen-induced cell death in breast cancer cells
Oncogene, 11/25/09
Adenosine A1 receptor, a target and regulator of estrogen receptor action, mediates the proliferative effects of estradiol in breast cancer
Oncogene, 11/25/09
Extrapulmonary small cell carcinoma in breast and prostate
Clinical and Translational Oncology, 11/25/09
Today in Diagnostics/Radiology...keeping you current
Receive free subspecialty "5-minute updates" via email
Routine use of ancillary investigations in staging diffuse large B-cell lymphoma improves the International Prognostic Index (IPI)
Journal of Hematology & Oncology, 11/25/09
Clinical relevance associated to the analysis of circulating tumour cells in patients with solid tumours
Clinical and Translational Oncology, 11/25/09
Prognostic and predictive factors and genetic analysis of early breast cancer
Clinical and Translational Oncology, 11/25/09
Sponsor
Article Search
Sponsor
Sponsor